XML 39 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaborations and Other Arrangements (Tables)
 9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of significant milestones and revenue recognized The table below summarizes the net milestones capitalized with respect to the Jardiance and Trajenta families of products and the net milestones deferred with respect to Basaglar as of September 30, 2022 and December 31, 2021:
Net Milestones Capitalized (Deferred)(1)
September 30, 2022December 31, 2021
Jardiance$121.2 $136.1 
Trajenta69.6 88.5 
Basaglar(135.3)(149.3)
(1) This represents the amounts that have been capitalized (deferred) from the start of this collaboration through the end of the reporting period, net of amount amortized.
The following table summarizes our collaboration and other revenue recognized with respect to the Jardiance and Trajenta families of products and net product revenue recognized with respect to Basaglar:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Jardiance$573.3 $390.4 $1,453.7 $1,058.9 
Basaglar193.0 192.8 558.7 650.1 
Trajenta103.8 96.1 293.0 279.9 
The following table summarizes our net product revenue recognized with respect to Olumiant:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Olumiant$182.9 $406.9 $624.7 $809.1 
The following table summarizes our revenue recognized in China with respect to Tyvyt:
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
Tyvyt$76.8 $125.6 $235.8 $340.2